Guillain–Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: Self-controlled case series
Authors:
- Nick AndrewsNANick Andrews
- Julia StoweJSJulia Stowe
- Rustam Al-Shahi SalmanRSRustam Al-Shahi Salman
- Elizabeth MillerEMElizabeth Miller
- 1 October 2011
- Vol. 29 (45) , 7878-7882
Abstract
No abstract availableKeywords
Funding Information
- Department of Health Policy Research Programs (039/0031)
- Medical Research Council
This publication has 12 references indexed in Scilit:
- Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety dataVaccine, 2011
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesThe Lancet, 2009
- The Epidemiology of Guillain-Barré Syndrome WorldwideNeuroepidemiology, 2008
- Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research DatabaseAmerican Journal of Epidemiology, 2008
- Case series analysis for censored, perturbed, or curtailed post-event exposuresBiostatistics, 2008
- Tutorial in biostatistics: the self‐controlled case series methodStatistics in Medicine, 2005
- Guillain-Barré Syndrome Following Influenza VaccinationJAMA, 2004
- Guillain-Barré syndromePostgraduate Medical Journal, 2000
- The reporting sensitivities of two passive surveillance systems for vaccine adverse events.American Journal of Public Health, 1995
- GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771American Journal of Epidemiology, 1979